NCT06354686View on ClinicalTrials.gov

Characterizing the Scalp Tolerability of TMS

NAActive, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 12, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2027

Conditions
Healthy
Interventions
DEVICE

TMS Tolerability

The primary objective is to characterize the tolerability of TMS by scalp location (over parietal, motor, modified Beam F3 prefrontal, THREE-D prefrontal, orbitofrontal, and medial prefrontal) and stimulation parameters (single pulse, 10 Hz, theta burst). The secondary objective is to evaluate the feasibility of the knee as a surrogate location to safely trial TMS parameters.

Trial Locations (1)

32306

Florida State University, Tallahassee

All Listed Sponsors
lead

Florida State University

OTHER

NCT06354686 - Characterizing the Scalp Tolerability of TMS | Biotech Hunter | Biotech Hunter